PFIZER INC — Director's Dealing 2023

Feb 25, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2023-02-22

Reporting Person: Dolsten Mikael (President R&D)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-22	Common Stock	F	32592.0000	$42.3800	Disposed	391223.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-02-23	Stock Appreciation Rights	$42.3000	A	137760.0000	Acquired	2028-02-23	Common Stock (137760.0000)	Direct
2023-02-23	Stock Appreciation Rights	$42.3000	A	119894.0000	Acquired	2030-02-23	Common Stock (119894.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1881.0000	Indirect

Footnotes

F1: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon).

F2: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

F3: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.